Literature DB >> 3311202

Recombinant gibbon interleukin 3 supports formation of human multilineage colonies and blast cell colonies in culture: comparison with recombinant human granulocyte-macrophage colony-stimulating factor.

A G Leary1, Y C Yang, S C Clark, J C Gasson, D W Golde, M Ogawa.   

Abstract

The genetic sequences encoding the gibbon and human interleukin 3 (IL 3) proteins were molecularly cloned. The amino acid sequence of the mature gibbon IL 3 protein proved to share 93% homology with the corresponding human protein. We examined the effects of biosynthetic (recombinant) gibbon IL 3 on the proliferation and differentiation of an enriched population of human hematopoietic progenitors and compared the results with the effects of recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF). Gibbon IL 3 supported the formation of various types of single lineage as well as multilineage colonies by My-10+ bone marrow cells in the presence of human erythropoietin (Ep). In contrast, recombinant human GM-CSF supported the formation of single-lineage colonies and only a small number of multilineage colonies. Both IL 3 and GM-CSF had significant erythroid burst-promoting activity (BPA). Delayed addition of gibbon IL 3 to low serum culture of My-10+ marrow cells supported the formation of blast cell colonies with variable but high replating capability. Human GM-CSF was less effective than IL 3 in support of multipotential blast cell colonies. These results are analogous to the effects of murine IL 3 and GM-CSF on murine progenitors and support the notion that the primary factor for multipotential progenitors is IL 3.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3311202

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  25 in total

Review 1.  Human lymphohematopoietic reconstitution and immune function in immunodeficient mice receiving cotransplantation of human thymic tissue and CD34(+) cells.

Authors:  Zheng Hu; Yong-Guang Yang
Journal:  Cell Mol Immunol       Date:  2012-02-06       Impact factor: 11.530

Review 2.  Polypeptides controlling hematopoietic cell development and activation. I. In vitro results.

Authors:  F Herrmann; R Mertelsmann
Journal:  Blut       Date:  1989-03

3.  Influence of IL-3 functional fragment on cord blood stem cell ex vivo expansion and differentiation.

Authors:  Zhihua Ren; Yu Zhang; Yanxi Zhang; Wenhong Jiang; Wei Dai; Xinxin Ding; Yongping Jiang
Journal:  Stem Cell Investig       Date:  2016-03-04

4.  Survival of hemopoietic progenitors in the G0 period of the cell cycle does not require early hemopoietic regulators.

Authors:  A G Leary; Y Hirai; T Kishimoto; S C Clark; M Ogawa
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

5.  Analysis in serum-free culture of the targets of recombinant human hemopoietic growth factors: interleukin 3 and granulocyte/macrophage-colony-stimulating factor are specific for early developmental stages.

Authors:  Y Sonoda; Y C Yang; G G Wong; S C Clark; M Ogawa
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

6.  Macrophages prevent human red blood cell reconstitution in immunodeficient mice.

Authors:  Zheng Hu; Nico Van Rooijen; Yong-Guang Yang
Journal:  Blood       Date:  2011-09-16       Impact factor: 22.113

Review 7.  Use and toxicity of the colony-stimulating factors.

Authors:  J R Schriber; R S Negrin
Journal:  Drug Saf       Date:  1993-06       Impact factor: 5.606

8.  An assessment of myeloid colony-forming-cell generation in liquid human bone marrow cultures: influence of accessory cells and cytokines IL-1 alpha, beta and IL-6.

Authors:  R P Gooding; P G Riches; M Y Gordon
Journal:  Int J Exp Pathol       Date:  1993-04       Impact factor: 1.925

9.  Chemical suppression of a subpopulation of primitive hematopoietic progenitor cells: 1,3-butadiene produces a hematopoietic defect similar to steel or white spotted mutations in mice.

Authors:  D B Colagiovanni; W S Stillman; R D Irons
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

Review 10.  Why clinicians should be interested in interleukin-3.

Authors:  P Valent; K Geissler; C Sillaber; K Lechner; P Bettelheim
Journal:  Blut       Date:  1990-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.